Wearable Aromatherapy Device for ADHD Behavioral Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for ADHD and other neural and mental disorders often rely on medication and harsh behavioral methods, which are costly and ineffective in addressing behavioral issues without understanding the underlying neural mechanisms.

Innovation Solution

A wearable aromatherapy device that emits specific scents to cue positive or negative behaviors by integrating with the limbic system of the brain, using a combination of pleasant and unpleasant fragrances to reinforce desired actions and extinguish undesired ones, accessible through a mobile app and remote control.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If medication and harsh behavioral methods are used to treat ADHD and behavioral disorders, then behavioral control is improved, but cost increases and side effects worsen

Engineering Contradiction:
Improvebehavioral controlVSAvoidside effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent introduces an olfactory intermediary (scent delivery system) that mediates between the treatment goal and the patient. Scents are delivered through a wearable device that releases aromatic compounds to influence behavior and emotions, avoiding direct pharmacological intervention while achieving behavioral control through sensory stimulation of the limbic system

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent replaces the mechanical/pharmaceutical system (medication) with an olfactory system (scent delivery). Instead of using chemical drugs that enter the bloodstream, the treatment uses inhaled aromatic compounds that directly stimulate the olfactory receptors and limbic system, substituting a different physiological pathway to achieve the same behavioral control outcome

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Reliability

If medication and specialized therapy are used to treat ADHD, then behavioral control is improved, but treatment cost increases

Engineering Contradiction:
Improvebehavioral controlVSAvoidtreatment cost
Core Design Contradiction:
ReliabilityVSLoss of energy

Solution Approach 1:

The patent employs a wearable device with replaceable scent cartridges that can be inexpensive and periodically replaced. The scent cartridges are simple consumable components that deliver therapeutic aromas without requiring complex medical infrastructure, making the treatment more affordable and accessible compared to ongoing medication and specialized therapy sessions

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The wearable scent delivery device is designed to be self-contained and easy to use, allowing patients or caregivers to administer treatment without requiring specialized medical personnel. The device automatically or manually releases scents as needed, reducing the need for costly professional intervention and monitoring

Inventive Principle:
Principle #25Self-service

3Reliability

If traditional therapy methods are used to address behavioral issues, then behavioral control is improved, but understanding of underlying neural mechanisms worsens

Engineering Contradiction:
Improvebehavioral controlVSAvoidneural mechanism understanding
Core Design Contradiction:
ReliabilityVSLoss of information

Solution Approach 1:

The patent segments the treatment approach by specifically targeting the olfactory-limbic pathway separately from other neural systems. By isolating and stimulating this specific neural route through scent delivery, the treatment provides insight into how this particular pathway influences behavior and emotions, contributing to understanding of neural mechanisms while maintaining behavioral control

Inventive Principle:
Principle #1Segmentation

Data Source

PatentUS11406789B2Therapy device and method of use
Publication Date: 2022.08.09 BIMLE CYNTHIA
  • US11406789B2 patent drawing
  • US11406789B2 patent drawing
  • US11406789B2 patent drawing

AI summary

The therapy device disclosed is structured and configured to be a wearable device self-controlled, remote controlled by a caregiver, and/or integrated with a downloadable application (app) from a mobile device to assist a caregiver with modifying and enforcing behaviors as aligned with olfactory sensation and personalized limbic system functionality. The device and system may also be configured and combined with another therapeutic device or medical monitoring system such that the therapy device disclosed herein is aligned to initiate when a target or monitored condition reaches a threshold value. Such configurations would allow the device to function automatically and in combination with data analytics.